EP3624837
ANTI-FGFR2 ANTIBODIES IN COMBINATION WITH CHEMOTHERAPY AGENTS IN CANCER TREATMENT
:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á Íslandi:
15.5.2018:
30.7.2025:
18730518.0
:
14.5.2038:
14.5.2026
:
ANTI-FGFR2 ANTIBODIES IN COMBINATION WITH CHEMOTHERAPY AGENTS IN CANCER TREATMENT
15.5.2018
30.7.2025
14.5.2026
:
Five Prime Therapeutics, Inc.:
111 Oyster Point Boulevard, South San Francisco, CA 94080, US
:
COLLINS, Helen L.:
South San Francisco California 94080, US
:
HNATYSZYN, James:
South San Francisco California 94080, US
:
XIANG, Hong:
South San Francisco California 94080, US
:
ZHANG, Xiang:
South San Francisco California 94080, US
:
201762507053 P:
16.5.2017:
US
:
201762581992 P:
6.11.2017:
US
:
US2018032757:
15.5.2018
:
A61K 39/00, A61K 39/395, C07K 16/22, C07K 16/28, A61P 35/00